drugset / Trial / NCT05888831
A Study of BMS-986449 With and Without Nivolumab in Participants With Advanced Solid Tumors
Non-randomizedSequentialOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy of BMS-986449 alone and in combination with nivolumab in participants with advanced solid tumors.
Timeline
- Start
- 2023-06-06
- Primary completion
- 2026-09-30
- Completion
- 2026-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-986449 | Unknown | — | — |
| Subject | Nivolumab | Monoclonal antibody | — | — |